VISUAL PERSEVERATION

VISUAL PERSEVERATION was reported 147 times

VISUAL PERSEVERATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 Provitamin D2 Compound [EPC] 6 0.0002
2 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
3 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 3 0.0001
4 Sigma-1 Agonist [EPC] 1 0.0001
5 Androgen [EPC] 3 0.0001
6 Orexin Receptor Antagonist [EPC] 2 0.0001
7 Carbonic Anhydrase Inhibitor [EPC] 2 0.0001
8 5-alpha Reductase Inhibitor [EPC] 8 0.0001
9 Muscle Relaxant [EPC] 2 0.0000
10 P2Y12 Platelet Inhibitor [EPC] 4 0.0000
11 Thiazide-like Diuretic [EPC] 1 0.0000
12 Prostaglandin Analog [EPC] 2 0.0000
13 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
14 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
15 Fluoroquinolone Antibacterial [EPC] 2 0.0000
16 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
17 Expectorant [EPC] 3 0.0000
18 alpha-Adrenergic Blocker [EPC] 2 0.0000
19 Nitrate Vasodilator [EPC] 1 0.0000
20 Aminosalicylate [EPC] 1 0.0000
21 Kinase Inhibitor [EPC] 5 0.0000
22 Aromatase Inhibitor [EPC] 1 0.0000
23 Sulfonylurea [EPC] 1 0.0000
24 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
25 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
26 Benzodiazepine [EPC] 5 0.0000
27 Calcium [EPC] 1 0.0000
28 beta-Adrenergic Blocker [EPC] 2 0.0000
29 Azole Antifungal [EPC] 1 0.0000
30 Vitamin B12 [EPC] 2 0.0000
31 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
32 Platelet Aggregation Inhibitor [EPC] 3 0.0000
33 Thiazide Diuretic [EPC] 1 0.0000
34 Vitamin C [EPC] 2 0.0000
35 Mood Stabilizer [EPC] 1 0.0000
36 Anti-epileptic Agent [EPC] 1 0.0000
37 GLP-1 Receptor Agonist [EPC] 2 0.0000
38 Atypical Antipsychotic [EPC] 2 0.0000
39 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
40 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
41 Progestin [EPC] 1 0.0000
42 Proton Pump Inhibitor [EPC] 2 0.0000
43 Osmotic Laxative [EPC] 1 0.0000
44 Vitamin D [EPC] 1 0.0000
45 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
46 Thalidomide Analog [EPC] 1 0.0000
47 Tumor Necrosis Factor Blocker [EPC] 1 0.0000